News and Trends 20 Dec 2016
UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data
…treated with uniQure’s AMT-060 gene therapy, which employs an adeno-associated viral vector to deliver a functional copy of the Factor IX (FIX) gene, required for adequate blood clotting. The patients,…